Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant in Type 2 Diabetic Patients With NASH
NCT00577148Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Feb 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 24
01
Overview
A Phase 3 trial of rimonabant in Nonalcoholic steatohepatitis (NASH), sponsored by Sanofi. Started Feb 2008; status: terminated.
02
Drugs
rimonabant
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00577148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577148.